Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,812,000 | 9,452,000 | 5,901,000 | 2,973,000 | 8,062,000 |
| Depreciation Amortization | 6,592,000 | 4,905,000 | 3,243,000 | 1,618,000 | 7,013,000 |
| Income taxes - deferred | -2,133,000 | -1,700,000 | -935,000 | -663,000 | -2,102,000 |
| Accounts receivable | -263,000 | N/A | N/A | N/A | -109,000 |
| Other Working Capital | -5,354,000 | -6,944,000 | -6,908,000 | -1,919,000 | -3,066,000 |
| Other Operating Activity | 5,050,000 | 643,000 | 452,000 | 326,000 | 2,946,000 |
| Operating Cash Flow | $11,704,000 | $6,356,000 | $1,753,000 | $2,335,000 | $12,744,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 928,000 | -323,000 | 1,747,000 | -2,720,000 | -2,869,000 |
| PPE Investments | -2,629,000 | -1,784,000 | -1,182,000 | -564,000 | -2,909,000 |
| Net Acquisitions | -6,927,000 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -294,000 | -215,000 | -86,000 | -134,000 | -180,000 |
| Sale Of Investment | 7,406,000 | 6,815,000 | 6,456,000 | 6,393,000 | 8,610,000 |
| Other Investing Activity | 165,000 | 302,000 | 290,000 | 299,000 | 0 |
| Investing Cash Flow | $-1,351,000 | $4,795,000 | $7,225,000 | $3,274,000 | $2,652,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -796,000 | -897,000 | -903,000 | -386,000 | 6,317,000 |
| Debt Issued | 9,678,000 | 3,687,000 | 3,687,000 | N/A | N/A |
| Debt Repayment | -6,757,000 | -3,750,000 | -3,750,000 | 0 | -2,250,000 |
| Dividend Paid | -9,771,000 | -7,326,000 | -4,882,000 | -2,437,000 | -9,512,000 |
| Other Financing Activity | -2,658,000 | -2,614,000 | -2,575,000 | -2,404,000 | -11,695,000 |
| Financing Cash Flow | $-10,304,000 | $-10,900,000 | $-8,423,000 | $-5,227,000 | $-17,140,000 |
| Exchange Rate Effect | 41,000 | 36,000 | 34,000 | -7,000 | -66,000 |
| Beginning Cash Position | 1,107,000 | 1,107,000 | 1,107,000 | 1,107,000 | 2,917,000 |
| End Cash Position | 1,197,000 | 1,394,000 | 1,694,000 | 1,481,000 | 1,107,000 |
| Net Cash Flow | $91,000 | $287,000 | $588,000 | $375,000 | $-1,810,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,704,000 | 6,356,000 | 1,753,000 | 2,335,000 | 12,744,000 |
| Capital Expenditure | -2,629,000 | -1,784,000 | -1,182,000 | -564,000 | -2,909,000 |
| Free Cash Flow | 9,075,000 | 4,572,000 | 571,000 | 1,771,000 | 9,835,000 |